AU2003242678A8 - Antisense oligonucleotides against pim1 - Google Patents

Antisense oligonucleotides against pim1

Info

Publication number
AU2003242678A8
AU2003242678A8 AU2003242678A AU2003242678A AU2003242678A8 AU 2003242678 A8 AU2003242678 A8 AU 2003242678A8 AU 2003242678 A AU2003242678 A AU 2003242678A AU 2003242678 A AU2003242678 A AU 2003242678A AU 2003242678 A8 AU2003242678 A8 AU 2003242678A8
Authority
AU
Australia
Prior art keywords
antisense oligonucleotides
oligonucleotides against
pim1
against pim1
antisense
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003242678A
Other versions
AU2003242678A1 (en
Inventor
Ozlem Altan
Arnold Grunweller
Volker Erdmann
Jens Kurreck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of AU2003242678A8 publication Critical patent/AU2003242678A8/en
Publication of AU2003242678A1 publication Critical patent/AU2003242678A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/12Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/323Chemical structure of the sugar modified ring structure
    • C12N2310/3231Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003242678A 2002-06-14 2003-06-12 Antisense oligonucleotides against pim1 Abandoned AU2003242678A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10226702.2 2002-06-14
DE2002126702 DE10226702A1 (en) 2002-06-14 2002-06-14 Antisense oligonucleotides against PIM1
PCT/EP2003/006158 WO2003106681A2 (en) 2002-06-14 2003-06-12 Antisense oligonucleotides against pim1

Publications (2)

Publication Number Publication Date
AU2003242678A8 true AU2003242678A8 (en) 2003-12-31
AU2003242678A1 AU2003242678A1 (en) 2003-12-31

Family

ID=29723183

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003242678A Abandoned AU2003242678A1 (en) 2002-06-14 2003-06-12 Antisense oligonucleotides against pim1

Country Status (3)

Country Link
AU (1) AU2003242678A1 (en)
DE (1) DE10226702A1 (en)
WO (1) WO2003106681A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033310A1 (en) * 2003-10-01 2005-04-14 Grünenthal GmbH Pim-1 specific dsrna compounds
DE102004004894A1 (en) * 2004-01-30 2005-08-18 Grünenthal GmbH Identifying substances that regulate PIM kinases, useful for treatment and diagnosis of urinary incontinence and the urge to urinate, and similar use of PIM proteins or nucleic acids
US20100048671A1 (en) * 2005-05-14 2010-02-25 Yun Qiu Inhibition of the 44 kilodalton isoform of pim-1 kinase restores apoptosis induced by chemotherapeutic drugs in cancer cells
ES2649156T3 (en) 2013-01-14 2018-01-10 Incyte Holdings Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
BR112015016793B1 (en) 2013-01-15 2021-12-28 Incyte Holdings Corporation COMPOUNDS OF THIAZOLACARBOXAMIDES AND PYRIDINECARBOXAMIDE, COMPOSITION COMPRISING THE SAME, METHOD OF INHIBITING THE ENZYME PIM1, PIM2, OR PIM3, AND USES OF SUCH COMPOUNDS
US9556197B2 (en) 2013-08-23 2017-01-31 Incyte Corporation Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
US9822124B2 (en) 2014-07-14 2017-11-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
US9540347B2 (en) 2015-05-29 2017-01-10 Incyte Corporation Pyridineamine compounds useful as Pim kinase inhibitors
AR105967A1 (en) 2015-09-09 2017-11-29 Incyte Corp SALTS OF A PIM QUINASA INHIBITOR
WO2017059251A1 (en) 2015-10-02 2017-04-06 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
TW201924683A (en) 2017-12-08 2019-07-01 美商英塞特公司 Low dose combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502912A1 (en) * 1995-01-31 1996-08-01 Hoechst Ag G-Cap Stabilized Oligonucleotides
WO1996039427A1 (en) * 1995-06-05 1996-12-12 Trustees Of Dartmouth College Ligand-stimulated gene expression
NO953680D0 (en) * 1995-09-18 1995-09-18 Hans Prydz Cell cycle Enzymes
EP0911391A3 (en) * 1997-10-24 2000-01-19 Smithkline Beecham Corporation A clone HWHHJ20
US6143540A (en) * 1999-01-26 2000-11-07 Millennium Pharmaceuticals, Inc. Molecules of the HKID-1-related protein family and uses thereof
AU3041701A (en) * 1999-12-23 2001-07-09 Exiqon A/S Therapeutic uses of lna-modified oligonucleotides
DE10037759A1 (en) * 2000-08-03 2002-07-04 Gruenenthal Gmbh screening process
DE10123055A1 (en) * 2001-05-11 2003-03-20 Gruenenthal Gmbh Screening method with PIM1-Kinase or PIM3-Kinase

Also Published As

Publication number Publication date
WO2003106681A2 (en) 2003-12-24
WO2003106681A3 (en) 2004-07-15
DE10226702A1 (en) 2004-09-09
AU2003242678A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
GB0219143D0 (en) Modified tailed oligonucleotides
GB0324728D0 (en) Targeted delivery
AU156991S (en) Dispenser
AU152182S (en) Dispenser
DE602004013036D1 (en) Us
AU2003242678A8 (en) Antisense oligonucleotides against pim1
AU157422S (en) Dispenser
PL361794A1 (en) Catheter
GB0213878D0 (en) Use
AU2003281867A8 (en) Antisense nucleic acids
AU152692S (en) Dispenser
AU151102S (en) Dispenser
AU151103S (en) Dispenser
GB0314557D0 (en) Improved reduction calculations
EP1525852A4 (en) Catheter
GB0224718D0 (en) Targeted delivery
AU157727S (en) Dispenser
GB2389841B (en) Dispensers
GB0212963D0 (en) Uni-rod rest
AU149249S (en) Dispenser
GB0212145D0 (en) Dispensers
AU149250S (en) Dispenser
AU152757S (en) Dispenser
GB0215929D0 (en) Third hand
AU2351P (en) Spindrift Erigeron karvinskianus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase